SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending due to a significant earnings beat, sparking optimism about the company's turnaround and increased demand for its processors. Community members are actively discussing the potential for a short squeeze, fueled by positive sentiment around the stock and government investment. The focus is on Intel's growth story amidst broader "make America" narratives, with anticipation for further announcements during the earnings call.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as community members discuss its potential expansion and TSA connections, particularly following news of its biometric platform deployment at Chicago O'Hare airport. The focus is on speculation around future airport contracts and the potential impact on earnings. Bullish sentiment seems to be building, with some anticipating a move towards double digits.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers ($DECK) is trending due to concerns about weakening consumer spending and the potential impact of tariffs, which have overshadowed strong brand performance from Hoka and UGG. Despite a recent earnings beat, the community is debating whether a buyback program will be enough to offset negative sentiment, with some fearing further downgrades and institutional sell-offs. Others see the dip as a buying opportunity, citing appealing valuation and potential for a quick bounce.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid speculation around potential U.S. government investment in quantum computing, fueled by a recent report. Community discussions revolve around whether this signals a long-term bullish outlook or is simply a pump and dump scheme, with some drawing comparisons to other hyped sectors and questioning the company's fundamentals and valuation.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending due to Jane Street disclosing a 5% stake, sparking discussions about potential manipulation and future deals, especially given the company's transition to HPC/data centers. The community is debating whether this investment is a positive catalyst or a strategic move to drag the stock down, while also anticipating news regarding a potential deal for 300 MW. Broader sentiment suggests a battle between bulls and bears, with some highlighting the company's strong positioning in the AI infrastructure space.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels Inc. is trending due to increased investor interest in rare earth minerals and uranium, fueled by geopolitical tensions and potential government contracts. The community is actively discussing unusual options activity, suggesting insider knowledge of upcoming positive news or government support. With significant call buying and a strategic position in domestic resource independence, UUUU is gaining attention as a key player in the energy and defense supply chain.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community rallies around the "We're All Gonna Make It" mantra, expressing strong conviction and long-term belief in the project. Discussions highlight the strength and support of the WAGMI community, with some anticipating significant growth and a potential surge in valuation. The meme-driven token is also drawing attention within the Solana ecosystem.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending amid discussions around its Q3 earnings, production adjustments, and the broader EV market. Community sentiment is mixed, with some expressing concerns about lowered profit guidance and the impact of a supplier fire, while others highlight positive sales figures and potential tariff relief. Overall, the stock's movement is tied to both company-specific news and the evolving dynamics of the automotive industry.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont (NEM) is trending amid discussions around its earnings call and CEO's response to questions about cash allocation, with some investors expressing frustration with the company's performance relative to gold. Despite an earnings beat, the stock's reaction is muted, leading to debates about valuation and future prospects, including potential share buybacks and the impact of gold prices. The community is also closely watching progress on the Ahafo North Project.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as the community draws parallels to other meme stocks like $BYND, sparking discussions around potential short squeezes and unusual options activity. Investors are closely monitoring the stock's support levels and potential catalysts, while also debating the influence of key figures like Ryan Cohen. Some users are speculating about a potential share buyback or insider buying, while others remain skeptical.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The Phase 2 trial showed VTX3232 cut key inflammation markers like hsCRP by about 78% and IL-6 to below risk thresholds, reinforcing its anti-inflammatory potential.</li><li>Combination treatment with semaglutide led to further reductions in liver inflammation and cardiovascular biomarkers, with no major safety issues reported.</li><li>On Stocktwits, retail traders debated whether VTX3232 holds greater promise as a combo therapy than a standalone drug.</li></ul>Retail chatter around Ventyx Biosciences surged&nbsp;late Wednesday after the biotechnology company announced positive topline results from a Phase 2 study of its oral anti-inflammatory drug, VTX3232, in participants with obesity and cardiovascular risk factors.<h2 class="st-heading-2">Strong Reductions In Inflammatory Markers</h2>The study followed 175 participants in the trial, which tested VTX3232 as both a standalone therapy and alongside semaglutide. These were compared to placebo groups.In a statement, Ventyx said those taking the drug demonstrated strong evidence of an anti-inflammatory effect of the drug as evidenced by reductions in two biomarkers of cardiovascular risk, high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6).In the monotherapy group, hsCRP levels decreased by approximately 78% by week 12, in contrast to an increase observed in the placebo group. Levels of IL-6 also dropped to below 1.65 nanograms per liter, which is a marker for lower heart risk.The firm also said the drug reduced levels of lipoprotein(a), fibrinogen, and liver inflammation, showing signs of an anti-inflammatory effect across multiple measures.<h2 class="st-heading-2">Expert View</h2>CEO Raju Mohan said the observed effects on hsCRP, IL-6, and Lp(a) suggest VTX3232 could represent a new class of oral anti-inflammatory therapies.Peter Libby, MD of Mass General Brigham, said elevated CRP levels are a strong predictor of cardiovascular risk and that new NLRP3 inhibitors may complement cholesterol-lowering treatments.Chief Medical Officer Mark Forman said VTX3232 “robustly inhibited the NLRP3 pathway,” adding that combination treatment with semaglutide achieved further reductions in inflammation-related biomarkers.<h2 class="st-heading-2">Stocktwits Traders See Combo Potential</h2>On Stocktwits, retail sentiment for Ventyx was ‘extremely bullish’ amid an 18,600% surge in 24-hour message volume.<figure class="image"><img style="aspect-ratio:974/139;" src="https://news.stocktwits-cdn.com/vtyx_ss_jpg_c8842a5cf1.webp" alt="vtyx ss.jpg" width="974" height="139"><figcaption>VTYX sentiment and message volume as of October 23 | Source: Stocktwits</figcaption></figure>One user&nbsp;expressed “mixed feelings” about the results, noting that while the data showed little effect on weight, liver disease (MASH), or lipids, VTX3232 appeared to be a strong candidate for use in combination therapies rather than as a standalone drug. They added that longer studies would be needed to define its target patient group and assess its value as a monotherapy.<stembedurl>https://stocktwits.com/aletz/message/633359533</stembedurl>Another user highlighted the company’s strong financial position, pointing out that Ventyx holds nearly $3 per share in cash and carries minimal debt.<stembedurl>https://stocktwits.com/Samb321/message/633346861</stembedurl><a href="https://stocktwits.com/symbol/VTYX">Ventyx’s stock</a> has risen 76% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Ventyx’s stock (VTYX) has risen 76% so far in 2025. (Photo credit: Getty Images)

Ventyx Biosciences Stock: Retail Buzz Spikes After Phase 2 Win In Obesity And Heart Risk Study

The Phase 2 trial showed VTX3232 cut key inflammation markers like hsCRP by about 78% and IL-6 to below risk thresholds, reinforcing its anti-inflammatory potential.

Equity

Ventyx Biosciences, Inc. (VTYX) Is Up 20.81% in One Week: What You Should Know 

Does Ventyx Biosciences, Inc. (VTYX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Ventyx Biosciences (VTYX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Ventyx Biosciences (VTYX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

VTYX Stock Rises on Strategic Equity Investment Deal With SNY

Shares of Ventyx Biosciences (NASDAQ: VTYX) gained 7% on Monday after the company announced that it has entered into a $27 million strategic investment agreement with Sanofi.
read more...

Ventyx Biosciences' Inflammatory Bowel Disease Candidate Flunks In Mid-Stage Study, Company Looks For Partner To Pursue It Further

Ventyx Biosciences stock down over 24% on Monday after Phase 2 trial results for Crohn's disease drug VTX958 did not meet primary endpoint.
read more...

VTYX DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX

VTYX DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX VTYX...

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ventyx Biosciences, Inc. (VTYX)

The Law Offices of Frank R. Cruz reminds investors of the upcoming April 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Ventyx...

VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX

VTYX DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc. Investors to Secure Counsel Before Important April 30 Deadline in Securities Class Action - VTYX VTYX...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTYX

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTYX SHAREHOLDER ALERT...

The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX

The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX The Gross Law Firm Reminds Ventyx...

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.45	--	--	N/A
Q2 '25	-$0.47	-$0.38	19.15%	BEAT
Q1 '25	-$0.48	-$0.39	19.47%	BEAT
Q4 '24	-$0.53	-$0.41	22.15%	BEAT
Q3 '24	-$0.52	-$0.50	3.38%	BEAT

VTYX
Ventyx Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest VTYX News

VTYXVentyx Biosciences Inc